{"id":8848,"date":"2025-12-04T23:02:23","date_gmt":"2025-12-04T23:02:23","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/12\/04\/fda-tracy-beth-hoeg-psychedelics-future-readout-loud-podcast\/"},"modified":"2025-12-04T23:02:23","modified_gmt":"2025-12-04T23:02:23","slug":"fda-tracy-beth-hoeg-psychedelics-future-readout-loud-podcast","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/12\/04\/fda-tracy-beth-hoeg-psychedelics-future-readout-loud-podcast\/","title":{"rendered":"A new top drug regulator and the future of psychedelics"},"content":{"rendered":"

A new top drug regulator and the future of psychedelics
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

On this week\u2019s episode of \u201cThe Readout Loud\u201d: a look at an emerging class of psychedelic drugs that may treat depression, anxiety, and other psychiatric conditions without the hallucinogenic \u201ctrip.\u201d Plus, a dash through the week\u2019s biotech news.\u00a0<\/p>\n

The turmoil at the Food and Drug Administration continues: Richard Pazdur<\/a> has announced his retirement from the agency, just a month after taking the job as top drug regulator. He\u2019s being replaced by Covid contrarian Tracy Beth H\u00f8eg<\/a>. We also discuss a U.K.-U.S pharma trade agreement<\/a>, a very large financing round for an AI-tinged longevity startup<\/a>, and a big Phase 3 study win for Capricor Therapeutics<\/a> and its Duchenne muscular dystrophy cell therapy.<\/p>\n

Read the rest\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Elaine Chen, Adam Feuerstein, and Allison DeAngelis
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

A new top drug regulator and the future of psychedelics On this week\u2019s episode of \u201cThe Readout Loud\u201d: a look at an emerging class of psychedelic drugs that may treat depression, anxiety, and other psychiatric conditions without the hallucinogenic \u201ctrip.\u201d Plus, a dash through the week\u2019s biotech news.\u00a0 The turmoil at the Food and Drug […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2280,2146,2432,2265],"tags":[2150],"class_list":["post-8848","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-clinical-trials","category-fda","category-mental-health","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8848"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8848"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8848\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}